ONZETRA Xsail for the Treatment of Migraine in Adults
ONZETRA Xsail is a Food and Drug Administration (FDA)-approved intranasal dry powder formulation developed by Avanir Pharmaceuticals.
Full Range CRO for Target Discovery, Screening, Lead Optimisation, Preclinical and Clinical Services
Mikonkatu 8,
FI-00100 Helsinki Other,
Finland
SBW is a consolidated CRO company that provides an extensive range of world-class services for drug discovery and development from our offices in seven locations in Europe and India. SBW is equipped with state-of-the-art instrumentation operated by experienced pharma professionals from multiple disciplines. All our services can be tailor-made to fit specific customer needs. Our experience includes working with over 100 pharma / biotech customers in more than 20 countries.
SBW has six business units, each with its own area of drug development expertise: Infodix, Biodix, Toxis, novamass, Medachem and 4Pharma.
We offer a full range of services for drug candidate validation: SBW provides a range of in silico, in vitro and in vivo services for drug discovery, including early target identification, hit to lead, lead optimisation and pre-clinical steps.
SBW also provides a range of services for clinical trials: biostatistics and data management, warehousing and analysis.
Infodix offers biological activity and scaffold hopping (US patent pending); quantitative physico-chemical and ADME property prediction; and systemic, organ-specific, and genetic toxicity and side-effect prediction (US patent pending). Other chemoinformatics services include the following.
Structure-based drug discovery:
Bioinformatics:
Workflow development:
Data mining and tailored software development:
Biodix covers:
Toxis deals with disease models, in vivo PK, and safety pharmacology and toxicology.
Disease models:
In vivo PK:
Safety pharmacology and toxicology:
We have around 30 in vivo disease models, including:
novamass handles metabolism studies, drug interaction studies and bioanalytical services.
Metabolism studies:
Drug interaction studies:
Bioanalytical services:
novamass also covers pharmacokinetic calculations, permeability studies and basic property characterisation.
Pharmacokinetic calculations:
Permeability studies:
Basic property characterisation:
Medachem offers the following medicinal chemistry services:
4Pharma’s key products are biostatistics, data management, data warehousing and bioinformatics.
4Pharma’s medical services include medical writing, medical coding, monitoring (through partners) and full clinical study (through partners).
4Pharma’s information technology expertise includes common technical document, remote data entry, electronic data capture (through partners) and pharmacovigilance (through partners).
ONZETRA Xsail is a Food and Drug Administration (FDA)-approved intranasal dry powder formulation developed by Avanir Pharmaceuticals.
Mikonkatu 8
FI-00100 Helsinki
Other
Finland